Monday, September 1, 2014 Last update: 11:03 AM - All Company Technology News Since 1996

Science / Research News

Wednesday, August 6, 2014

  • Posted at 4:11 AM
    Compugen Ltd. (NASDAQ: CGEN) today reported financial results for the second quarter ending June 30, 2014. Dr. Anat Cohen-Dayag, Compugen’s President and CEO, stated, "During the first six months of this year, our R&D efforts focused primarily on ... read more
  • Posted at 3:02 AM
    OncoSec Medical Inc. (OTCQB: ONCS), a company developing its ImmunoPulse DNA-based intratumoral cancer immunotherapy, has appointed Dr. Holbrook Kohrt, M.D., Ph.D., to the company’s Scientific Advisory Board. Dr. Kohrt joins a growing panel of distinguished experts and renowned thought leaders, and will contribute ... read more
  • Posted at 3:00 AM
    CytRx Corporation (CYTR), a biopharmaceutical research and development company specializing in oncology, today reported financial results for the three months ended June 30, 2014, and also provided an overview of recent accomplishments and upcoming milestones for its clinical development programs. ... read more

Tuesday, August 5, 2014